Study of ZGGS18 in Patients With Advanced Solid Tumors

Clinical trial NCT05584800 · RECRUITING

Trial details

NCT number: NCT05584800
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-11-15
Primary completion: 2026-11-01
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.